A pharma giant wants to talk to decision-makers at Queen's Park about the health system.
AbbVie Corporation was registered by Nico Johnson, a consultant with McMillan Vantage, with the main focus of advocating for the value of innovative pharmaceuticals in improving patient outcomes and overall savings to the healthcare system, as well as advancing health security and economic growth. They also wanted to discuss partnership opportunities with the Government of Ontario, regional health authorities, cancer agencies, and universities in clinical research on new and existing treatments and therapies, and the generation of real-world evidence, as well as how the client can help support health system improvements and healthcare outcomes.
New Registrations